Pentixapharm says shareholders exercise rights for 9,096,771 new shares in capital raise

Reuters2026/07/22 10:40

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pentixapharm completed a rights offering tied to its capital increase, with subscription rights exercised for 9,096,771 new shares.
The take-up rate reached 82.5% of the planned issuance, including oversubscription.
Gross proceeds from the rights offering totaled about EUR 16.8 million.
1,923,441 unsubscribed new shares remain, offered to institutional investors via private placement through July 28 at EUR 1.85 each.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pentixapharm Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2369974_en) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pentixapharm says shareholders exercise rights for 9,096,771 new shares in capital raise

You may also like

Crypto prices